KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Retained Earnings (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Retained Earnings readings, the most recent being -$2.5 billion for Q1 2026.

  • On a quarterly basis, Retained Earnings rose 83.21% to -$2.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was -$2.5 billion, a 83.21% increase, with the full-year FY2025 number at -$13.8 billion, down 337.17% from a year prior.
  • Retained Earnings hit -$2.5 billion in Q1 2026 for Teva Pharmaceutical Industries, up from -$13.8 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$287.0 million in Q1 2023 to a low of -$15.0 billion in Q1 2025.
  • Median Retained Earnings over the past 5 years was -$11.7 billion (2022), compared with a mean of -$8.4 billion.
  • Biggest five-year swings in Retained Earnings: soared 87.44% in 2023 and later tumbled 866.9% in 2024.
  • Teva Pharmaceutical Industries' Retained Earnings stood at -$2.5 billion in 2022, then increased by 5.17% to -$2.4 billion in 2023, then plummeted by 32.05% to -$3.1 billion in 2024, then crashed by 337.17% to -$13.8 billion in 2025, then skyrocketed by 81.75% to -$2.5 billion in 2026.
  • The last three reported values for Retained Earnings were -$2.5 billion (Q1 2026), -$13.8 billion (Q4 2025), and -$14.2 billion (Q3 2025) per Business Quant data.